Clinical Trial

TRIO CTO (Taiwan Research Initiative on Coronary Total Occlusion)

Recruiting
View on ClinicalTrials.gov →
Summary
Coronary chronic total occlusions (CTO) present a significant challenge in the field of interventional cardiology. These complex lesions, characterized by complete blockage of a coronary artery for a prolonged duration, often require specialized techniques and strategies to achieve successful revascularization.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-31; most recent amendment 2025-12-10.
Trial Details
NCT Number NCT06917378
Lead Sponsor National Taiwan University Hospital
Collaborators: Chang Gung Memorial Hospital, Taipei Veterans General Hospital, Taiwan
Conditions Chronic Total Occlusion (CTO)
Enrollment 5,000 participants
Start Date 2017-01-01
Primary Completion 2034-12-31 (estimated)
Study Completion 2034-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-18